Institutional Biosafety Committee

The NIH Institutional Biosafety Committee (IBC) provides recommendations to the Director of the NIH or his designee, in matters pertaining to the control of hazards associated with the intramural use of microbiological agents, their vectors, and recombinant DNA. The committee serves as an advisory body to the Division of Occupational Health and Safety (DOHS), Office of Research Services (ORS).

Recombinant DNA and Pathogen Registration submissions are submitted electronically through the Electronic Registration System (ERS). Please check the NIH: IBC Meeting and Deadline Dates for Bethesda campus and RML IBC Meeting and Deadline Dates for Rocky Mountain Lab (RML) campus . Membership roster for RML IBC Committee :RML IBC Membership.

Membership Roster

Name	Committee Role
Harry L. Malech	Chairperson, Clinican
Richard G. Baumann	Biological Safety Officer, Voting Contact
Robert Craigie	Committee Member, Clinician
Alicia Alexion	Local Non-Affiliated
Jocelyn Dunford-Weissman	Senior Research Associate
Avijeet( and Ishveen) Chopra	Scientific Technical Writers
Althea Treacy	Associate Biological Safety Officer, QPSO Lead
Lauren Reoma	Committee Member, Clinician
Jeanne Billioux	Committee Member, Clinician
Michael Kujawa	Commmittee Member, IBC Coordinator
Stephen L. Denny	Animal Expert, Animal Program Director
Clevetta Drew	Local Non-Affiliated
Stephanie M. Goff	Committee Member
Steve S. Whitehead	Committee Member, Virologist